AAP
NUVB icon

Arax Advisory Partners’s Nuvation Bio NUVB Stock Holding History

Arax Advisory Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Buy
+33,249
New +$163K ﹤0.01% 2290
2026
Q1 		– Sell
-36
Closed -$323 – 4166
2025
Q4 		$323 Sell
36
-39,275
-100% -$243K ﹤0.01% 3664
2025
Q3 		$145K Buy
+39,311
New +$107K ﹤0.01% 1389
2025
Q1 		– Sell
-234
Closed -$623 – 2927
2024
Q4 		$623 Hold
234
– – ﹤0.01% 2278
2024
Q3 		$536 Hold
234
– – ﹤0.01% 2391
2024
Q2 		$684 Buy
+234
New +$714 ﹤0.01% 2274

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arax Advisory Partners's NUVB Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Nuvation Bio (NUVB) in Q2 2026: 33,249 shares worth $189K. The stake represents ﹤0.01% of the portfolio and ranks #2290 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in NUVB as recently as Q4 2025.

Arax Advisory Partners first reported a position in NUVB in Q2 2024 and has held it in 6 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Arax Advisory Partners held 33,249 shares of Nuvation Bio worth $189K as of Q2 2026.
  • Nuvation Bio was a new Arax Advisory Partners position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2290 holding.
  • Arax Advisory Partners first reported a position in Nuvation Bio in Q2 2024 and has held it in 6 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.